Design and Therapeutic Application of Matrix Metalloproteinase Inhibitors

This publication has 308 references indexed in Scilit:

• Selective replacement of the catalytic zinc of the human stromelysin-1 catalytic domain
  JBIC Journal of Biological Inorganic Chemistry, 1998
• KB-R7785, a novel matrix metalloproteinase inhibitor, exerts its antidiabetic effect by inhibiting tumor necrosis factor-α production
  Life Sciences, 1997
• Selection of a histidine-containing inhibitor of gelatinases through deconvolution of combinatorial tetrapeptide libraries
  Molecular Diversity, 1997
• The Helping Hand of Collagenase-3 (MMP-13): 2.7 Å Crystal Structure of its C-terminal Haemopexin-like Domain
  Journal of Molecular Biology, 1996
• Interaction of Peptide Substrates of Fibroblast Collagenase with Divalent Cations: Ca2+ Binding by Substrate as a Suggested Recognition Signal for Collagenase Action
  Biochemical and Biophysical Research Communications, 1995
• Intra-articular injection of stromelysin into rabbit knees as a model to evaluate matrix metalloprotease inhibitors
  Inflammation Research, 1995
• Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790
  Inflammation Research, 1995
• Inhibition of Matrix Metalloproteinases by Peptidyl Hydroxamic Acids
  Biochemical and Biophysical Research Communications, 1994
• Inhibition of human collagenases by sulfur-based substrate analogs
  Biochemical and Biophysical Research Communications, 1991
• Peptide hydroxamic acids inhibit skin collagenase
  Biochemical and Biophysical Research Communications, 1986